John J. Wright

3.1k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

John J. Wright is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, John J. Wright has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in John J. Wright's work include Chemical Synthesis and Analysis (9 papers), Photosynthetic Processes and Mechanisms (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). John J. Wright is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Photosynthetic Processes and Mechanisms (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). John J. Wright collaborates with scholars based in United States, United Kingdom and Germany. John J. Wright's co-authors include Seth M. Steinberg, Richard Piekarz, Susan E. Bates, Judy Hirst, William D. Figg, Maxie M. Roessler, Robin Frye, Mark Kirschbaum, Steven L. Allen and Jasmine Zain and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John J. Wright

61 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

2009 561 citations Richard Piekarz, Robin Frye et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John J. Wright United States	27	1.5k	443	276	260	253	65	2.4k
Dennis S. France United States	21	1.6k 1.0×	524 1.2×	276 1.0×	192 0.7×	202 0.8×	50	2.6k
E. Moustacchi France	45	4.8k 3.2×	688 1.6×	377 1.4×	123 0.5×	145 0.6×	169	6.0k
Hitoshi Sezaki Japan	33	1.2k 0.8×	700 1.6×	312 1.1×	103 0.4×	112 0.4×	121	3.1k
Beatriz Montaner Spain	26	837 0.6×	400 0.9×	126 0.5×	97 0.4×	658 2.6×	37	2.9k
N R Bachur United States	22	992 0.7×	609 1.4×	402 1.5×	125 0.5×	120 0.5×	43	2.1k
Masaru Takeshita Japan	27	3.8k 2.5×	768 1.7×	403 1.5×	270 1.0×	356 1.4×	71	5.0k
Laurie E. Grove United States	17	842 0.6×	506 1.1×	102 0.4×	319 1.2×	152 0.6×	35	1.6k
Leonard C. Erickson United States	34	3.0k 2.0×	956 2.2×	420 1.5×	188 0.7×	73 0.3×	95	4.1k
Julie L. Eiseman United States	34	2.1k 1.4×	733 1.7×	195 0.7×	103 0.4×	302 1.2×	131	3.5k
Tatyana Sandalova Sweden	32	1.5k 1.0×	230 0.5×	208 0.8×	65 0.3×	546 2.2×	84	2.7k

Countries citing papers authored by John J. Wright

Since Specialization

Citations

This map shows the geographic impact of John J. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Wright more than expected).

Fields of papers citing papers by John J. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Wright. The network helps show where John J. Wright may publish in the future.

Co-authorship network of co-authors of John J. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Wright. A scholar is included among the top collaborators of John J. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Wright. John J. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grba, Daniel N., John J. Wright, Zhan Yin, William W. Fisher, & Judy Hirst. (2024). Molecular mechanism of the ischemia-induced regulatory switch in mammalian complex I. Science. 384(6701). 1247–1253. 9 indexed citations

Wright, John J., et al.. (2023). Using light scattering to assess how phospholipid–protein interactions affect complex I functionality in liposomes. RSC Chemical Biology. 4(6). 386–398. 3 indexed citations

Wright, John J., Mantas Šimėnas, William K. Myers, et al.. (2021). Functional basis of electron transport within photosynthetic complex I. Nature Communications. 12(1). 5387–5387. 25 indexed citations

Grba, Daniel N., Andrew J. Y. Jones, Wei Song, et al.. (2021). A conserved arginine residue is critical for stabilizing the N2 FeS cluster in mitochondrial complex I. Journal of Biological Chemistry. 296. 100474–100474. 8 indexed citations

Biner, Olivier, et al.. (2021). Paracoccus denitrificans: a genetically tractable model system for studying respiratory complex I. Scientific Reports. 11(1). 10143–10143. 15 indexed citations

Bridges, Hannah R., Justin G. Fedor, James N. Blaza, et al.. (2020). Structure of inhibitor-bound mammalian complex I. Nature Communications. 11(1). 5261–5261. 78 indexed citations

Wright, John J., Justin G. Fedor, Judy Hirst, & Maxie M. Roessler. (2020). Using a chimeric respiratory chain and EPR spectroscopy to determine the origin of semiquinone species previously assigned to mitochondrial complex I. BMC Biology. 18(1). 54–54. 22 indexed citations

Adamson, Hope, Martin Robinson, John J. Wright, et al.. (2017). Retuning the Catalytic Bias and Overpotential of a [NiFe]-Hydrogenase via a Single Amino Acid Exchange at the Electron Entry/Exit Site. Journal of the American Chemical Society. 139(31). 10677–10686. 64 indexed citations

Wright, John J., et al.. (2016). Small-volume potentiometric titrations: EPR investigations of Fe-S cluster N2 in mitochondrial complex I. Journal of Inorganic Biochemistry. 162. 201–206. 21 indexed citations

10.

Mahalingam, Devalingam, Laeeq Malik, Muralidhar Beeram, et al.. (2014). Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma. Cancer Chemotherapy and Pharmacology. 74(1). 77–84. 24 indexed citations

11.

Amiri‐Kordestani, Laleh, Victoria Luchenko, Cody J. Peer, et al.. (2013). Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers. Clinical Cancer Research. 19(16). 4499–4507. 57 indexed citations

12.

Meanwell, Nicholas A., Owen B. Wallace, Milind Deshpande, et al.. (2009). Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity. Bioorganic & Medicinal Chemistry Letters. 19(17). 5136–5139. 34 indexed citations

13.

Lieu, Christopher H., Laura Q.M. Chow, A. Scott Pierson, et al.. (2008). A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. Investigational New Drugs. 27(1). 53–62. 7 indexed citations

14.

Zhao, Ming, Michelle A. Rudek, Ping He, et al.. (2006). A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay. Journal of Chromatography B. 846(1-2). 1–7. 48 indexed citations

15.

Laurent, Denis R. St., Niranjan Balasubramanian, Wenfei Han, et al.. (1995). Active site-directed thrombin inhibitors-II. Studies related to arginine/guanidine bioisosteres. Bioorganic & Medicinal Chemistry. 3(8). 1145–1156. 15 indexed citations

16.

Balasubramanian, Niranjan, Denis R. St. Laurent, Marianne E. Federici, et al.. (1993). Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series. Journal of Medicinal Chemistry. 36(2). 300–303. 43 indexed citations

17.

Meanwell, Nicholas A., Piyasena Hewawasam, James A. Thomas, et al.. (1993). Inhibitors of blood platelet cAMP phosphodiesterase. 4. Structural variation of the side-chain terminus of water-soluble 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives. Journal of Medicinal Chemistry. 36(22). 3251–3264. 9 indexed citations

18.

Meanwell, Nicholas A., Michael Rosenfeld, John J. Wright, et al.. (1993). Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted .alpha. to the oxazole ring. Journal of Medicinal Chemistry. 36(24). 3871–3883. 19 indexed citations

19.

Meanwell, Nicholas A., et al.. (1992). Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility. Journal of Medicinal Chemistry. 35(14). 2688–2696. 8 indexed citations

20.

Clifford, Michael N., et al.. (1991). Is there a role for amines other than histamines in the aetiology of scombrotoxicosis?. Food Additives & Contaminants. 8(5). 641–651. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact